London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...
The company also develops cancer treatments for multiple myeloma, ovarian cancer, and endometrial cancer in addition to other drugs. GSK plc (NYSE:GSK) reported solid financial results for fiscal ...
GSK plc announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment ...
Analysts are pounding the table on these tech stocks.
GSK Overseas Services Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1.0 lakhs ...
Tony Wood, GSK’s chief scientific officer, acknowledged it might be easier to communicate the company’s potential if he could point to “one big drug”, but said: “It is in some ways an ...
Sir Jonathan Symonds, Chair of GSK, expressed the company's enthusiasm about Dr Screaton joining the Board, highlighting his deep expertise in fields that are central to GSK's scientific endeavors.
The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent ... Motilal Oswal also increased its earnings estimate for the company by 2 percent/5 percent/7 percent ...
GSK's revenue and EPS exceeded my expectations ... What are the reasons for the slight but still falling revenue of the London-based company? A more precise and comprehensive answer to the above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results